Bristol-Myers Squibb Company (BMY) Valuation — DCF & Advanced Analysis | MarketCI

BMY

Market Closed

Bristol-Myers Squibb Company

NYSEHealthcare Drug Manufacturers - General

32.50K employees

CEO: Christopher S. Boerner

Founded: 1972

$63.63

+$0.00(+NaN%)

Market Cap

129.98B

Beta

0.23

52W Range

N/A

Dividend Yield

3.94%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: Bristol-Myers Squibb's current price at $63.63 is significantly below its PERT-weighted fair value of $143.82, indicating substantial upside potential supported by strong DCF and growth scores. Low leverage but moderate liquidity suggests manageable financial risk, while the Monte Carlo model shows high volatility but zero downside below current price. This valuation spread signals opportunities amid inherent market uncertainty.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore BMY

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples